TW200744625A - HCV inhibitors - Google Patents
HCV inhibitorsInfo
- Publication number
- TW200744625A TW200744625A TW095123601A TW95123601A TW200744625A TW 200744625 A TW200744625 A TW 200744625A TW 095123601 A TW095123601 A TW 095123601A TW 95123601 A TW95123601 A TW 95123601A TW 200744625 A TW200744625 A TW 200744625A
- Authority
- TW
- Taiwan
- Prior art keywords
- compounds
- present
- hcv inhibitors
- directed
- hcv
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention is directed to compounds that are antiviral agents. Specifically the compounds of the present invention inhibit replication of HCV and are therefore useful in treating hepatitis C infections. The present invention is also directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69576705P | 2005-06-30 | 2005-06-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200744625A true TW200744625A (en) | 2007-12-16 |
TWI449711B TWI449711B (en) | 2014-08-21 |
Family
ID=39933853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095123601A TWI449711B (en) | 2005-06-30 | 2006-06-29 | Hcv inhibitors |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN101242816B (en) |
TW (1) | TWI449711B (en) |
ZA (1) | ZA200711069B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102413079B1 (en) * | 2014-05-28 | 2022-06-24 | 어젠시스 인코포레이티드 | Derivatives of dolaproine-dolaisoleuine peptides |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1136498A1 (en) * | 1996-10-18 | 2001-09-26 | Vertex Pharmaceuticals Incorporated | Inhibitors of serine proteases, particularly hepatitis c virus NS3 protease |
US6323180B1 (en) * | 1998-08-10 | 2001-11-27 | Boehringer Ingelheim (Canada) Ltd | Hepatitis C inhibitor tri-peptides |
CN102372764A (en) * | 2000-07-21 | 2012-03-14 | 先灵公司 | Novel peptides as NS3-serine protease inhibitors of hepatitis c virus |
KR101115294B1 (en) * | 2003-05-21 | 2012-04-12 | 베링거 인겔하임 인터내셔날 게엠베하 | Hepatitis C inhibitor compounds |
MY148123A (en) * | 2003-09-05 | 2013-02-28 | Vertex Pharma | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
-
2006
- 2006-06-29 ZA ZA200711069A patent/ZA200711069B/en unknown
- 2006-06-29 CN CN2006800296080A patent/CN101242816B/en not_active Expired - Fee Related
- 2006-06-29 TW TW095123601A patent/TWI449711B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TWI449711B (en) | 2014-08-21 |
CN101242816B (en) | 2012-10-31 |
CN101242816A (en) | 2008-08-13 |
ZA200711069B (en) | 2009-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007016324A (en) | Hcv inhibitors. | |
TW200635596A (en) | Pyridazinone compounds | |
JO2593B1 (en) | HCV NS3 Protease Inhibitors | |
MY164469A (en) | Hcv ns3 protease inhibitors | |
HK1123733A1 (en) | Viral hepatitis treatment | |
ATE551337T1 (en) | HEPATITIS C VIRUS INHIBITORS | |
SG163517A1 (en) | Antiviral compounds and methods | |
IL196815A0 (en) | Hepatitis c virus inhibitors | |
MX2011006631A (en) | Hcv ns3 protease inhibitors. | |
WO2008057208A3 (en) | Hcv ns3 protease inhibitors | |
WO2008051514A3 (en) | Hcv ns3 protease inhibitors | |
WO2008051475A3 (en) | Hcv ns3 protease inhibitors | |
SI1987038T1 (en) | Hcv ns5b inhibitors | |
MY186633A (en) | Heterocyclic compounds as inhibitors of hepatitis c virus (hcv) | |
MX2011009644A (en) | Hepatitis c virus inhibitors. | |
WO2006119061A3 (en) | Hcv ns3 protease inhibitors | |
MX2009010564A (en) | 5,6-dihydro-1h-pyridin-2-one compounds. | |
UA90909C2 (en) | Hcv ns3 protease inhibitors | |
MX2008001541A (en) | Methods for the preparation of hcv polymerase inhibitors. | |
WO2007005779A3 (en) | Antiviral agents | |
TW200744625A (en) | HCV inhibitors | |
UA95990C2 (en) | Hcv ns3 protease inhibitors | |
TW200716123A (en) | Pteridines useful as HCV inhibitors and methods for the preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |